Utility and cost-effectiveness of LiverMultiScan for MASLD diagnosis: a real-world multi-national randomised clinical trial

Adding mpMRI to SoC for the management of adults with suspected MASLD multi-nationally is cost-effective, enhances rate of diagnosis multi-nationally and increases rate of diagnosis without increasing other liver-related health care resource use. Due to the need for standardisation of SoC, widespread use can support optimisation of the MASLD clinical pathway and improve long-term patient management.

Authors

Institutions

Publication Details

Journal
Communications Medicine
Published
2025-03-18
DOI
https://doi.org/10.1038/s43856-025-00796-9
Citations
13
Primary Topic
Liver Disease Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
17.60

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Utility and cost-effectiveness of LiverMultiScan for MASLD diagnosis: a real-world multi-national randomised clinical trial

Stephen T. Barclay, Andrew Fraser, Elizabeth Shumbayawonda, Daniel Forton et al.
13 citations
Communications Medicine
Liver Disease Diagnosis and Treatment
17.60
article

Utility and cost-effectiveness of LiverMultiScan for MASLD diagnosis: a real-world multi-national randomised clinical trial

Stephen T. Barclay, Andrew Fraser, Elizabeth Shumbayawonda, Daniel Forton, Saima Ajaz, Janisha Patel, Paula Lorgelly, Cayden Beyer, Michael H. Miller, Jelte J. Schaapman, Matthias Dollinger, Jane Elizabeth Carolan, Johanna Backhus, Minneke J. Coenraad, Rajarshi Banerjee, Hildo J. Lamb, Kosh Agarwal, Daniel James Cuthbertson, Marika French, Dimitar Tonev, Christopher D. Byrne, Miguel Castelo‐Branco
article en
13 citations

Abstract

Adding mpMRI to SoC for the management of adults with suspected MASLD multi-nationally is cost-effective, enhances rate of diagnosis multi-nationally and increases rate of diagnosis without increasing other liver-related health care resource use. Due to the need for standardisation of SoC, widespread use can support optimisation of the MASLD clinical pathway and improve long-term patient management.

Communications MedicineVol. 5(1)
St George's Hospital (GB), University of Liverpool (GB), St. Elizabeth Hospital in Enumclaw (US), Leiden University Medical Center (NL), Glasgow Royal Infirmary (GB), Southampton General Hospital (GB), Ninewells Hospital (GB), University Hospital Southampton NHS Foundation Trust (GB), King's College Hospital (GB), University Hospital Ulm (DE), Queen Elizabeth University Hospital (GB), University of Southampton (GB), University College London (GB), University of Coimbra (PT)
NIHR Biomedical Research Centre, Royal Marsden NHS Foundation Trust/Institute of Cancer Research, National Institute for Health and Care Research, European Commission, Horizon 2020 Framework Programme
Openalex Percentile: Top 1%
Liver Disease Diagnosis and Treatment
17.60
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.